N-[(2RS)-(+/-)-2-BENZYLOXYCARBONYLAMINO-2-(DIISOPROPOXYPHOSPHINYL)-ACETYL]-GLYCINE-TERT.-BUTYLESTER
Compound with spectra: 1 NMR
![N-[(2RS)-(+/-)-2-BENZYLOXYCARBONYLAMINO-2-(DIISOPROPOXYPHOSPHINYL)-ACETYL]-GLYCINE-TERT.-BUTYLESTER](/api/compound/9K1ufIUdcpm.png?ph=true&h=300&w=458 "N-[(2RS)-(+/-)-2-BENZYLOXYCARBONYLAMINO-2-(DIISOPROPOXYPHOSPHINYL)-ACETYL]-GLYCINE-TERT.-BUTYLESTER")
| SpectraBase Compound ID | 9K1ufIUdcpm |
|---|---|
| InChI | InChI=1S/C22H35N2O8P/c1-15(2)31-33(28,32-16(3)4)20(19(26)23-13-18(25)30-22(5,6)7)24-21(27)29-14-17-11-9-8-10-12-17/h8-12,15-16,20H,13-14H2,1-7H3,(H,23,26)(H,24,27) |
| InChIKey | BGKWHMJAUXJGAK-UHFFFAOYSA-N |
| Mol Weight | 486.5 g/mol |
| Molecular Formula | C22H35N2O8P |
| Exact Mass | 486.213103 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
2-[(3R,4S)-3-(benzyloxycarbonylamino)-4-ethyl-2-keto-piperidino]acetic acid tert-butyl ester
2-Diethoxyphosphoryl-2-[[(2S)-2-[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]-1-oxopropyl]amino]acetic acid ethyl ester
BENZYLOXYCARBONYL-VALINE-GLYCINE-(TERT-BUTYLOXYCARBONYL)LYSINE-(TERT-BUTYLOXYCARBONYL)LYSINE TETRAPEPTIDE
BENZYLOXYCARBONYL-VALINE-GLYCINE-(TERT-BUTYLOXYCARBONYL)LYSINE-(TERT-BUTYLOXYCARBONYL)LYSINE-HYDRAZIDE TETRAPEPTIDE
BENZOYLOXYCARBONYL-ASPARTYL(O-TERT-BUTYL)-D-PHENYLALANINE-NH2 PEPTIDE(L-D)
Z-L-PHE-L-LEU-OBZL
Cbz-Ser(rprenyl)-Lle-OMe
METHYL-N-(BENZYLOXYCARBONYL)-ALANYLPHENYLALANYLPHENYLALANYLALANINE
(R,S)-2-[(1-BENZYLOXYCARBONYLAMINO-2-METHYL-PROPYL)-HYDROXY-PHOSPHINOYLMETHYL]-MALONIC-ACID-DIETHYLESTER
ETHYL-N-(BENZYLOXYCARBONYL)-GLYCYLPHENYLALANYLPHENYLALANYLGLYCYLGLYCINE
| Title | Journal or Book | Year |
|---|---|---|
| Phosphono Analogues of Glutathione as New Inhibitors of Glutathione S-Transferases | Archiv der Pharmazie | 1996 |